MAPT and dementia: Moreover, in the work by Roy et al., the age-related cognitive impairment occurred in the mouse model overexpressing a human mutant Tau form (P301L) known to result in dementia (rTg4510) could be prevented by the administration of a selective p38αMAPK inhibitor, further strengthening the role of this specific kinase in Tau-related pathology [97].